Gollob Jared's Form 4 filing
Kymera Therapeutics, Inc. (KYMR) · filed Oct 14, 2025
- Accession no.
- 0001193125-25-239144
- Filed
- Oct 14, 2025
- Trade date
- Oct 13, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $186.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gollob JaredCIK 0001821198 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2025 | Common Stock | MOption exerciseAcquired | +800 | $1.31 | +$1,048 | 120,800 | Direct | |
| Oct 13, 2025 | Common Stock | MOption exerciseAcquired | +673 | $2.08 | +$1,399.84 | 121,473 | Direct | |
| Oct 13, 2025 | Common Stock | SSaleDisposed | −3,114 | $60.00 | −$186,840 | 118,359 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2025 | Common Stock | MOption exerciseDisposed | −800 | $0.00 | $0 | 28,999 | Direct | |
| Oct 13, 2025 | Common Stock | MOption exerciseDisposed | −673 | $0.00 | $0 | 22,210 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.